Central Nervous System (CNS) | Drug Research, Discovery & Development | Charles River

central nervous system  

 
 

With an aging population, better rates of diagnosis, and an increase of central nervous system diseases after the age of 65, there is a mounting need to discover and develop more innovative and effective therapeutic treatments focused on the central nervous system.

Charles River offers a wide range of services supported by our scientific depth, unique technical capabilities, and experience in all the major neurodegenerative diseases and neurological indications, such as Alzheimer’s disease, Parkinson’s disease, chronic pain, epilepsy, Multiple Sclerosis, stroke, and more. From animal models of disease and preclinical testing to clinical trials, we have developed the tools to assist clients in shortening the development cycle of compounds with neurological implications. 

Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jul 01 Charles River Announces RMS Succes...
Jun 01 Contract Pharma: CRO Industry Upda...
Jul 06-Jul 10 Perth, Australia The 2009 Australian Society for Microbiology (ASM) A...
Aug 18-Aug 21 Charleston, SC Charles River’s Annual LAL Workshop
view all
Quality Assurance Inspector Canada - QC -...
Principal Investigator I Tacoma, WA
Sr. Quality Assurance Auditor Frederick, ...
Global Loss Control Specialist, Finance 

Charles River Laboratories, Inc.